Analyst Price Targets — GMED
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 25, 2026 2:37 pm | Richard Newitter | Truist Financial | $115.00 | $94.32 | TheFly | Globus Medical price target raised to $115 from $105 at Truist |
| January 30, 2026 11:46 am | — | Needham | $112.00 | $90.22 | TheFly | Globus Medical upgraded to Buy from Hold at Needham |
| January 26, 2026 9:39 pm | — | Cowen & Co. | $110.00 | $92.98 | TheFly | Globus Medical initiated with a Buy at TD Cowen |
| January 9, 2026 11:37 am | — | Canaccord Genuity | $112.00 | $94.62 | TheFly | Globus Medical price target raised to $112 from $105 at Canaccord |
| January 8, 2026 11:56 am | Matt O'Brien | Piper Sandler | $115.00 | $90.54 | TheFly | Globus Medical price target raised to $115 from $90 at Piper Sandler |
| December 17, 2025 12:26 pm | Shagun Singh | RBC Capital | $100.00 | $85.79 | TheFly | Globus Medical price target raised to $100 from $92 at RBC Capital |
| December 17, 2025 12:14 pm | Caitlin Cronin | Canaccord Genuity | $105.00 | $85.79 | TheFly | Globus Medical price target raised to $105 from $90 at Canaccord |
| October 28, 2025 10:50 am | Thomas Stephan | Stifel Nicolaus | $64.00 | $63.46 | TheFly | Globus Medical resumed with a Hold at Stifel |
| October 10, 2025 1:35 pm | — | RBC Capital | $88.00 | $57.55 | TheFly | Globus Medical price target lowered to $88 from $95 at RBC Capital |
| December 2, 2024 11:18 am | Kallum Titchmarsh | Morgan Stanley | $100.00 | $85.52 | StreetInsider | Morgan Stanley Upgrades Globus Medical (GMED) to Overweight |
Latest News for GMED
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is This the Right Time to Add Globus Medical Stock to Your Portfolio?
GMED gains share in musculoskeletal solutions with spine growth, rapid product launches and strong cash, but macro headwinds and rising costs remain risks.
Globus Medical (GMED) Upgraded to Strong Buy: What Does It Mean for the Stock?
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for March 4th
ORN, LRCX, GMED, MYRG and CPRX have been added to the Zacks Rank #1 (Strong Buy) List on March 4, 2026.
GE Aerospace, Nuclear Play Lead 5 Stocks Near Buy Points
GE stock is among this list of fast-growers that haven't lost momentum.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.